Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia.

Biomedicines · 2024 · PMC10968097 · PMID 38540200

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

We previously demonstrated increased myocardial perfusion, enhanced ventricular relaxation, and a strong trend towards increased cardiac output using our validated large animal mode of chronic myocardial ischemia [ 19 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.